Inventor · disambiguated record
Daewoong Jo
Also filed as: JO DAEWOONG
19 granted patents·16 pending applications·61 citations·filing 2001–2021
93Inventor score
Top patents by PatentIndex Score
35 records- 0195US10385103B2Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereofCELLIVERY THERAPEUTICS INC·Filed 2017·Granted Aug 20, 2019·7 cites·16 claims
- 0292US10781241B2Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereofCELLIVERY THERAPEUTICS INC·Filed 2017·Granted Sep 22, 2020·3 cites·11 claims
- 0391US8420096B2Cell-penetrating SOCS polypeptides that inhibit cytokine-induced signalingHAWIGER JACK J·Filed 2005·Granted Apr 16, 2013·26 cites·21 claims
- 0490US10975132B2Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereofCELLIVERY THERAPEUTICS INC·Filed 2019·Granted Apr 13, 2021·2 cites·7 claims
- 0590US10961292B2Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereofCELLIVERY THERAPEUTICS INC·Filed 2019·Granted Mar 30, 2021·2 cites·8 claims
- 0688US10787492B2Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereofCELLIVERY THERAPEUTICS INC·Filed 2017·Granted Sep 29, 2020·2 cites·12 claims
- 0787US10689424B2Cell-permeable (CP)-Δ SOCS3 recombinant protein and uses thereofCELLIVERY THERAPEUTICS INC·Filed 2019·Granted Jun 23, 2020·2 cites·13 claims
- 0887US10323072B2Cell-permeable (CP)-Δ SOCS3 recombinant protein and uses thereofCELLIVERY THERAPEUTICS INC·Filed 2018·Granted Jun 18, 2019·2 cites·13 claims
- 0987US10323063B2Advanced macromolecule transduction domain (aMTD) sequences for improvement of cell-permeability, polynucleotides encoding the same, method to identify the unique features of aMTDs comprising the same, method to develop the aMTD sequences comprising the sameCELLIVERY THERAPEUTICS INC·Filed 2015·Granted Jun 18, 2019·3 cites·5 claims
- 1085US10508265B2Cell-permeable reprogramming factor (iCP-RF) recombinant protein and use thereofCELLIVERY THERAPEUTICS INC·Filed 2018·Granted Dec 17, 2019·3 cites·14 claims
- 1184US10669531B2Cell-permeable Cre (iCP-Cre) recombinant protein and use thereofCELLIVERY THERAPEUTICS INC·Filed 2018·Granted Jun 2, 2020·2 cites·17 claims
- 1284US10662419B2Cell-permeable (ICP) parkin recombinant protein and use thereofCELLIVERY THERAPEUTICS INC·Filed 2018·Granted May 26, 2020·2 cites·18 claims
- 1375US11279743B2Cell-permeable bone morphogenetic protein (CPBMP) recombinant protein and use thereofCELLIVERY THERAPEUTICS INC·Filed 2020·Granted Mar 22, 2022·0 cites·7 claims
- 1475US8450279B2Cell permeable Nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the sameJO DAEWOONG·Filed 2008·Granted May 28, 2013·4 cites·21 claims
- 1572US10774123B2Cell-permeable bone morphogenetic protein (CP-BMP) recombinant protein and use thereofCELLIVERY THERAPEUTICS INC·Filed 2018·Granted Sep 15, 2020·0 cites·12 claims
- 1666US8445443B2Cell permeable p18 recombinant proteins, polynucleotides encoding the same, and anticancer composition comprising the sameJO DAEWOONG·Filed 2008·Granted May 21, 2013·1 cites·24 claims
- 1765US2017137482A1Cell-permeable (icp)-socs3 recombinant protein and uses thereofJO DAEWOONG·Filed 2016·Application pending·0 cites
- 1862US2016060319A1Development of Protein-Based Biotherapeutics That Induced Osteogenesis for Bone Healing Therapy: Cell-Permeable BMP2 and BMP7 Recombinant Proteins (CP-BMP2 & CP-BMP7), Polynucleotides Encoding the Same and Pro-osteogenic Compositions Comprising the SameJO DAEWOONG·Filed 2015·Application pending·0 cites
- 1957US8470971B2Cell permeable p53 recombinant protein, polynucleotide encoding the same, and anti-cancer composition containing the same as active ingredientJO DAEWOONG·Filed 2009·Granted Jun 25, 2013·0 cites·30 claims
- 2057US2016060310A1Development of Protein-Based Biotherapeutics That Penetrates Cell-Membrane and Induces Anti-Hepatocellular Carcinoma Effect - Improved Cell-Permeable Suppressor of Cytokine Signaling (iCP-SOCS3) Proteins, Polynucleotides Encoding the Same, and Anti-Hepatocellular Carcinoma Compositions Comprising the SameJO DAEWOONG·Filed 2015·Application pending·0 cites
- 2157US2023357339A1Development of Cell-Permeable Truncated SOCS3 SH2 Domain (CP-SD) Recombinant Protein for Anti-Obesity AgentCELLIVERY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2257US2023073000A1Improved Cell-Permeable Modified Parkin Recombinant Protein for Treatment of Neurodegenerative Diseases and Use ThereofCELLIVERY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2357US2016060312A1Development of Protein-Based Biotherapeutics That Penetrates Cell-Membrane and Induces Anti-Pancreatic Cancer Effect - Improved Cell-Permeable Suppressor of Cytokine Signaling (iCP-SOCS3) Proteins, Polynucleotides Encoding the Same, and Anti-Pancreatic Cancer Compositions Comprising the SameJO DAEWOONG·Filed 2015·Application pending·0 cites
- 2457US2016060314A1Development of a Protein-Based Biotherapeutic Agent That Penetrates Cell-Membrane and Induces Anti-Tumor Effect in Solid Tumors - Improved Cell-Permeable Suppressor of Cytokine Signaling (iCP-SOCS3) Proteins, Polynucleotides Encoding the Same, and Anti-Tumor Compositions Comprising the SameJO DAEWOONG·Filed 2015·Application pending·0 cites
- 2557US2016060311A1Development of Protein-Based Biotherapeutics That Penetrates Cell-Membrane and Induces Anti-Lung Cancer Effect - Improved Cell-Permeable Suppressor of Cytokine Signaling (iCP-SOCS3) Proteins, Polynucleotides Encoding the Same, and Anti-Lung Cancer Compositions Comprising the SameJO DAEWOONG·Filed 2015·Application pending·0 cites
- 2655US8586544B2Cell-permeable endostatin recombinant protein, a polynucleotide encoding the same, and an anti-cancer preparation containing the same as an active componentJO DAEWOONG·Filed 2009·Granted Nov 19, 2013·0 cites·18 claims
- 2755US2016060313A1Development of Protein-Based Biotherapeutics That Penetrates Cell-Membrane and Induces Anti-Angiogenic Effect - Improved Cell-Permeable Suppressor of Cytokine Signaling (iCP-SOCS3) Proteins, Polynucleotides Encoding the Same, and Anti-Angiogenic Compositions Comprising the SameJO DAEWOONG·Filed 2015·Application pending·0 cites
- 2851US2023039219A1Improved Cell-Permeable Nuclear Import Inhibitor Synthetic Peptide for Inhibition of Cytokine Storm or Inflammatory Disease and Use ThereofCELLIVERY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2948US11319546B2Cell-permeable (CP)-Cas9 recombinant protein and uses thereofCELLIVERY THERAPEUTICS INC·Filed 2017·Granted May 3, 2022·0 cites·20 claims
- 3047US2011021442A1Cell preamble runx3 recombinant proteins, polynucleotides encoding the same, and anticancer compositions including the sameJO DAEWOONG·Filed 2008·Application pending·0 cites
- 3141US2003027335A1Genome engineering by cell-permeable DNA site-specific recombinasesFiled 2001·Application pending·0 cites
- 3235US2017029798A1Development of Improved Cell-Permeable (iCP) Parkin Recombinant Protein as a Protein-Based Anti-Neurodegenerative Agent for the Treatment of Parkinson's Disease-Associated Phenotypes by Utilizing BBB-Penetrating Protein Delivery System MITT, Enabled by Advanced Macromolecule Transduction Domain (aMTD)JO DAEWOONG·Filed 2015·Application pending·0 cites
- 3332US2016068825A1Development of Protein-Based Biotherapeutics That Penetrate Cell-Membrane and Induce Anti-Cancer Effect- Cell-Permeable Glutathione Peroxidase7 (CP-GPX7) in Gastrointestinal Track (GIT), Polynucleotides Encoding the Same, and Anti-Cancer Compositions Comprising the SameJO DAEWOONG·Filed 2015·Application pending·0 cites
- 3430US2012095188A1Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapyJO DAEWOONG·Filed 2010·Application pending·0 cites
- 3529US2016083441A1Development of Protein-Based Biotherapeutics That Penetrate Cell-Membrane and Induce Anti-Cancer Effect - Cell-Permeable Trefoil Factor 1 (CP-TFF1) in Gastrointestinal Track (GIT) Cancer, Polynucleotides Encoding The Same, and Anti-Cancer Compositions Comprising The SameJO DAEWOONG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daewoong Jo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →